Financials

Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-58.23
Rapporto prezzo/fatturato
97.79

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
990
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
83.91 USD+0.24%+0.49%+137.98%+104.16%8.85 B USD
1005
SYRE
Spyre Therapeutics, Inc. - Common Stock
101.65 USD+2.73%+9.58%+21.68%+325.14%8.83 B USD
1021
APGE
Apogee Therapeutics, Inc. - Common Stock
134.26 USD+0.22%+0.58%+55.77%+150.53%8.31 B USD
1023
TGTX
TG Therapeutics, Inc. - Common Stock
55.85 USD+1.75%-1.33%+11.39%+45.86%8.55 B USD

Notizie